Connect with us

Health

COVID-19: Dexamethasone discovery carries treatment implications – Micky News

Patients with comorbidities may not fully get the help of Dexamethasone, a new study suggests it may reduce their drug potential.

Published

on

post featured image

Dexamethasone is one of the potential drugs that has seen a positive effect for those people with COVID-19, most especially for the critically-ill. But a new study suggests that it would not fully have the potential for those patients with diabetes and low albumin levels.
A team made the findings of scientists from the University of Virginia School of Medicine, University of Poland, and the University of South Carolina. According to News-Medical, the findings show that serum albumin, a protein found…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending